Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3. [electronic resource]
Producer: 20140716Description: 23-30 p. digitalISSN:- 1423-0100
- Adult
- Antiviral Agents -- therapeutic use
- Drug Therapy, Combination -- methods
- Fatty Acids, Monounsaturated -- therapeutic use
- Female
- Fluvastatin
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Indoles -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Prospective Studies
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.